Maynard Um
-
-
-
-
-
-
-
Citi Adjusts Catalyst Watch List
-
-
-
-
-
-
-
Tandem Diabetes Care (TNDM) PT Raised to $22 at Stifel Following Q4 Revenue Beat
-
-
-
-
-
-
-
Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference
-
-
-
-
-
-
-
Tandem Diabetes Care study shows insulin delivery system benefits type 2 patients
-
-
-
-
-
-
-
Piper Sandler Downgrades Tandem Diabetes Care (TNDM) to Neutral
-
-
-
-
-
-
-
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
-
-
-
-
-
-
-
Morgan Stanley Downgrades Tandem Diabetes Care (TNDM) to Equalweight
-
406,187 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

